Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Here's Why McKesson Corporation Stock Is Climbing Today

What happened

Shares of McKesson Corporation  (NYSE: MCK  ) , America's largest pharmaceutical distributor, have risen 8.8% as of 11:20 a.m. EDT on Friday. A fiscal 2017 earnings report released after yesterday's bell was awfully encouraging.

So what

During the year ended March 31, McKesson's GAAP earnings rose 137% over the previous-year period to $23.28 per share. Before getting too excited, though, it's important to realize that figure includes $14.10 per share related to the Change Healthcare joint venture.

Excited person in front of an upward-sloping chart.

Image source: Getty Images.

About $1.25 billion in cash proceeds that fluffed up earnings this year were due to a one-time event, but there were other nuggets of encouragement in the company's full-year report. Despite the relentless downward pressure U.S. end payers have applied to pharmaceutical prices recently, North American distribution and services revenue of $164.8 billion was 4% higher than in the previous year.

Now what

McKesson is expecting this year to be a tough one. In fiscal 2018, management expects GAAP earnings to reach between $7.10 and $8.80 per share, which is well below the amount reported this year after subtracting cash received in connection with the formation of Change Healthcare.

To overcome industry headwinds, McKesson has been making acquisitions left and right. Adjusting for non-cash charges mainly related to those acquisitions, though, raises the company's earnings expectations to between $11.75 and $12.45 for fiscal 2018. At recent prices, the stock is trading at just 13.1 times the low end of this year's adjusted earnings estimate. The road ahead might be a bumpy one, but at this price, the stock looks like a bargain.

10 stocks we like better than McKesson
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and McKesson wasn't one of them! That's right -- they think these 10 stocks are even better buys.

Click here to learn about these picks!

*Stock Advisor returns as of May 1, 2017

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 4020281, ~/Articles/ArticleHandler.aspx, 5/26/2017 5:28:49 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 8 hours ago Sponsored by:
Change up DOW 21083.0 70.5 0.3%
Change up S&P 500 2415.1 10.7 0.4%
Change up NASD 6205.3 42.2 0.7%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/25/2017 4:01 PM
MCK $162.36 Up +1.13 +0.70%
McKesson CAPS Rating: *****